TauRx Team

The TauRx team includes highly skilled and internationally recognised pharmaceutical experts for both R&D strategic planning and implementation including clinical trial design, execution, data analysis and product registration. The company’s Executive Chairman is co-founder Professor Claude M. Wischik.

See these sections for more information about the TauRx Team:

First Evidence of Potential Efficacy of Tau Aggregation Inhibitor Therapy in Alzheimer’s Disease

TauRx Completes Recruitment to Phase 3 Alzheimer’s Disease Studies